<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 67 year old man presented with non-invasive <z:hpo ids='HP_0100522'>thymoma</z:hpo>, associated <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> and important <z:hpo ids='HP_0004313'>hypogammaglobulinemia</z:hpo>; the postoperative course has been characterized, three months later, by <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> (kept under control with steroid therapy) and, two years later, by squamous <z:e sem="disease" ids="C0242379" disease_type="Neoplastic Process" abbrv="">lung cancer</z:e>, not susceptible of surgical treatment </plain></SENT>
<SENT sid="1" pm="."><plain>The patient died five years after operation because of progression of the <z:e sem="disease" ids="C0242379" disease_type="Neoplastic Process" abbrv="">lung cancer</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0001903'>Anemia</z:hpo> improved only partially after operation; there where no effects on <z:hpo ids='HP_0004313'>hypogammaglobulinemia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0100522'>Thymoma</z:hpo> has been reported in literature in 50% of patients with <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, 7-13% of adult patients with <z:hpo ids='HP_0004313'>hypogammaglobulinemia</z:hpo> is affected by <z:hpo ids='HP_0100522'>thymoma</z:hpo>, in 21% of patients that presented with <z:hpo ids='HP_0100522'>thymoma</z:hpo> other <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> have been discovered through clinical history </plain></SENT>
</text></document>